Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Bevacizumab in Patients With Severe Covid-19

  • Read more about Bevacizumab in Patients With Severe Covid-19

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

  • Read more about Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

NO Prevention of COVID-19 for Healthcare Providers

  • Read more about NO Prevention of COVID-19 for Healthcare Providers

Mechanisms for Organ Dysfunction in Covid-19

  • Read more about Mechanisms for Organ Dysfunction in Covid-19

Norwegian Coronavirus Disease 2019 Study

  • Read more about Norwegian Coronavirus Disease 2019 Study

Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)

  • Read more about Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)

COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2

  • Read more about COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

  • Read more about COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir

  • Read more about COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir

Outcomes and Prognostic Factors in COVID-19

  • Read more about Outcomes and Prognostic Factors in COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 279
  • Page 280
  • Page 281
  • Page 282
  • Current page 283
  • Page 284
  • Page 285
  • Page 286
  • Page 287
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA